NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 17 04:00PM ET
11.92
Dollar change
-0.23
Percentage change
-1.89
%
IndexRUT P/E63.00 EPS (ttm)0.19 Insider Own4.15% Shs Outstand10.94M Perf Week-9.28%
Market Cap130.38M Forward P/E- EPS next Y-1.49 Insider Trans0.00% Shs Float10.48M Perf Month-15.70%
Income2.09M PEG- EPS next Q-0.27 Inst Own82.34% Short Float13.19% Perf Quarter-23.59%
Sales602.46M P/S0.22 EPS this Y-157.07% Inst Trans-2.85% Short Ratio5.98 Perf Half Y-33.03%
Book/sh19.21 P/B0.62 EPS next Y-41.90% ROA0.68% Short Interest1.38M Perf Year-63.04%
Cash/sh14.84 P/C0.80 EPS next 5Y- ROE1.02% 52W Range11.88 - 36.29 Perf YTD-32.35%
Dividend Est.- P/FCF7.66 EPS past 5Y-50.52% ROI0.95% 52W High-67.16% Beta0.98
Dividend TTM- Quick Ratio2.68 Sales past 5Y4.45% Gross Margin73.80% 52W Low0.34% ATR (14)0.62
Dividend Ex-DateSep 18, 2023 Current Ratio3.34 EPS Y/Y TTM-97.89% Oper. Margin0.48% RSI (14)32.66 Volatility4.27% 4.50%
Employees504 Debt/Eq0.08 Sales Y/Y TTM-43.80% Profit Margin0.35% Recom3.00 Target Price15.00
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q-86.79% Payout0.00% Rel Volume0.58 Prev Close12.15
Sales Surprise0.81% EPS Surprise166.67% Sales Q/Q-37.70% EarningsApr 28 AMC Avg Volume231.09K Price11.92
SMA20-9.80% SMA50-15.21% SMA200-31.26% Trades Volume133,380 Change-1.89%
Date Action Analyst Rating Change Price Target Change
Nov-05-24Upgrade DA Davidson Underperform → Neutral $16.50 → $17
Jun-05-24Downgrade DA Davidson Neutral → Underperform $25 → $17.50
Oct-13-23Initiated Stephens Equal-Weight $82
Nov-04-22Downgrade DA Davidson Buy → Neutral $278 → $106
Aug-04-22Downgrade Jefferies Buy → Hold $345 → $150
Jan-25-21Upgrade Jefferies Hold → Buy $205 → $265
Nov-05-20Upgrade DA Davidson Neutral → Buy $180 → $205
Jun-25-20Initiated B. Riley FBR Buy $164
Feb-27-20Downgrade Jefferies Buy → Hold $130 → $90
Nov-08-19Downgrade Dougherty & Company Buy → Neutral
Apr-15-25 11:10AM
Apr-14-25 04:05PM
Apr-10-25 05:07AM
Apr-08-25 05:10AM
Mar-28-25 09:21AM
02:05AM Loading…
Feb-19-25 02:05AM
Feb-18-25 05:55PM
04:58PM
04:42PM
04:05PM
Feb-17-25 08:02AM
Feb-04-25 04:05PM
Jan-07-25 08:30AM
08:30AM
Dec-19-24 05:59PM
08:00AM Loading…
Dec-09-24 08:00AM
Dec-05-24 08:30AM
Dec-04-24 11:30AM
Dec-03-24 03:08AM
03:00AM
Dec-02-24 08:55AM
Nov-27-24 03:09AM
Nov-11-24 02:34AM
Nov-07-24 09:40AM
Nov-05-24 10:00AM
Nov-04-24 05:45PM
04:45PM
04:36PM
04:05PM
Nov-03-24 02:10AM
04:05PM Loading…
Oct-21-24 04:05PM
Oct-09-24 01:00PM
Sep-11-24 02:01PM
03:42AM
Sep-06-24 03:48AM
Sep-04-24 11:30AM
03:32AM
Aug-26-24 10:04AM
Aug-14-24 09:32AM
Aug-06-24 07:21AM
Aug-05-24 05:55PM
04:54PM
04:19PM
04:05PM
Aug-04-24 03:01AM
Aug-02-24 09:20AM
Jul-22-24 04:05PM
07:00AM
Jul-17-24 03:18AM
Jul-16-24 09:35AM
07:05AM
04:02AM
Jul-11-24 07:16AM
Jul-05-24 06:24AM
Jul-03-24 05:24AM
Jul-02-24 03:42AM
Jul-01-24 05:18AM
Jun-28-24 06:50AM
02:46AM
Jun-17-24 08:00AM
Jun-14-24 06:37AM
Jun-12-24 01:20PM
Jun-11-24 08:21AM
02:45AM
Jun-09-24 01:07AM
Jun-07-24 06:09PM
Jun-06-24 05:41AM
May-31-24 05:03AM
May-30-24 06:10AM
May-24-24 06:55AM
May-20-24 03:02PM
08:00AM
May-13-24 03:12PM
May-09-24 11:46AM
06:20AM
May-06-24 03:04AM
May-01-24 09:40AM
Apr-30-24 02:31PM
12:04PM
11:36AM
08:19AM
08:01AM
07:31AM
06:21AM
03:04AM
Apr-29-24 08:54PM
05:53PM
04:46PM
04:25PM
04:05PM
Apr-28-24 03:01AM
Apr-18-24 03:35AM
Apr-16-24 12:53PM
08:57AM
Apr-15-24 04:05PM
Apr-10-24 04:52AM
Apr-09-24 05:02AM
Apr-08-24 05:16AM
Apr-05-24 05:53AM
Apr-04-24 04:47AM
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.